Crawford Comes Under House Democrat Fire For Postmarket Safety Lapses
This article was originally published in The Gray Sheet
Executive Summary
FDA could seek authority to require device and drug firms to conduct postmarket safety studies, Commissioner Lester Crawford suggested July 26 during a House Appropriations/Agriculture, Rural Development & Related Agencies Subcommittee hearing